Home Newsletters Prostate Cell News ISL1 Promotes Enzalutamide Resistance in Castration-Resistant Prostate Cancer (CRPC) through Epithelial to...

ISL1 Promotes Enzalutamide Resistance in Castration-Resistant Prostate Cancer (CRPC) through Epithelial to Mesenchymal Transition (EMT)

0
The authors revealed the important role of insulin gene enhancer-binding protein 1 (ISL1) in androgen receptor (AR)-dependent prostate cancer cell growth; ISL1 knockdown reduced the AR activity and cell growth.
[Scientific Reports]

Sorry, but the selected Zotpress account can't be found.

Full Article
Exit mobile version